The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. Genetics and Mol. Res. 2026;25(1):1-25. doi:10.4238/1fvw5h08